"Drugs" Mixed Media Screen Print
Davisionary
$40.00
Angle
Ships to: United States
Ships in 3-5 Days
About
10"x15" Mixed Media Screen Print, Limited Edition, Individually signed & numbered, each piece hand painted and printed, each one a little different then the next.
Frame not included, but available
“Few quality-assured sources exist.”
For many people, finding drugs to treat Drug Resistant Tuberculosis (DR-TB) is nearly impossible, as only one or two quality-assured source exists, depending on the drug.
Although there has been some recent progress in increasing access to drugs—with a decrease in the number of products that had only one supplier, down from 11 in 2008 to four in 2011—for all of these medicines, supply is extremely vulnerable to disruption.
First-line TB treatment costs $19 per patient for a six-month treatment course. Yet the cost of DR-TB treatment is considerably more expensive, and this acts as a barrier to treatment communities and large populations. Yet another barrier is the cost of human resources for monitoring and medical and psychological care.
TB drugs purchased through the World Health Organization (WHO) can cost between $4,400 and almost $9,000 per patient for a standard 18-24 month treatment course. For drugs purchased outside of the WHO, prices may be even higher. High prices are a direct result of a insufficient market competition. They are also a consequence of limited demand for DR-TB drugs; manufacturers keep prices high in order to make a profit from the low demand.
Credit: “DR-TB Drugs Under The Microscope”, March 2011.
Source: Campaign For Access to Essential Medicines & International Union Against Tuberculosis and Lung Disease
Simple Solutions?
Drug prices are a particularly frustrating barrier to care for two reasons. First, other human beings control them, whereas rainfall cannot be controlled. Drug manufacturers are motivated by recovering costs and making profits. A simple solution is to appeal to drug manufacturers and governments to make life-saving drugs accessible to the world’s poorest. A sliding scale for drug prices would allow the poorest to purchase drugs at a reduced cost. In addition, improved diagnostic testing that diagnoses patients more quickly and effectively with DR-TB will increase demand for more of these drugs, thereby lowering their costs.
Second, costs are not born equally around the world; hospitals in the U.S. happily spend the thousands of dollars per patient to treat Americans. But in poor, rural communities, people die because it’s not deemed cost effective to spend such a large sum on just one person. This is solved by changing attitudes. Let’s be honest about our values and question why our children are worth more than children in other countries.
Do you love it?
$40.00
Be the first to leave a comment!
To leave a comment, login or signup.
